HEADER APOPTOSIS 28-MAR-17 5VB1 OBSLTE 23-MAY-18 5VB1 6DCN TITLE BCL-XL COMPLEX WITH BECLIN 1 BH3 DOMAIN T108PTHR COMPND MOL_ID: 1; COMPND 2 MOLECULE: BCL-XL PROTEIN; COMPND 3 CHAIN: D, B; COMPND 4 SYNONYM: BCL2-L-1,APOPTOSIS REGULATOR BCL-X; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BECLIN-1; COMPND 8 CHAIN: A, C; COMPND 9 SYNONYM: COILED-COIL MYOSIN-LIKE BCL2-INTERACTING PROTEIN,PROTEIN COMPND 10 GT197; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 GENE: BECN1, GT197; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 13 EXPRESSION_SYSTEM_STRAIN: K-12 KEYWDS APOPTOSIS, BCL-2, AUTOPHAGY, BECLIN 1 EXPDTA X-RAY DIFFRACTION AUTHOR E.F.LEE,B.J.SMITH,S.YAO,W.D.FAIRLIE REVDAT 2 23-MAY-18 5VB1 1 OBSLTE REVDAT 1 04-APR-18 5VB1 0 JRNL AUTH E.F.LEE,B.J.SMITH,S.YAO,W.D.FAIRLIE JRNL TITL STRUCTURAL INSIGHTS INTO BCL-2 PRO-SURVIVAL PROTEIN JRNL TITL 2 INTERACTIONS WITH THE KEY AUTOPHAGY REGULATOR PROTEIN BECLIN JRNL TITL 3 1 FOLLOWING PHOSPHORYLATION BY MST1 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.44 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.44 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 22378 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.9435 - 5.8867 1.00 1603 158 0.1760 0.2214 REMARK 3 2 5.8867 - 4.6736 1.00 1506 147 0.1746 0.2118 REMARK 3 3 4.6736 - 4.0832 1.00 1468 144 0.1515 0.1657 REMARK 3 4 4.0832 - 3.7100 1.00 1472 144 0.1685 0.2066 REMARK 3 5 3.7100 - 3.4442 1.00 1455 144 0.1869 0.2146 REMARK 3 6 3.4442 - 3.2412 1.00 1455 142 0.1944 0.2616 REMARK 3 7 3.2412 - 3.0789 1.00 1456 143 0.2128 0.2404 REMARK 3 8 3.0789 - 2.9449 1.00 1426 140 0.2255 0.3018 REMARK 3 9 2.9449 - 2.8315 1.00 1448 142 0.2051 0.2602 REMARK 3 10 2.8315 - 2.7338 1.00 1434 140 0.2176 0.2723 REMARK 3 11 2.7338 - 2.6483 1.00 1424 141 0.2143 0.2630 REMARK 3 12 2.6483 - 2.5726 1.00 1431 139 0.2378 0.2896 REMARK 3 13 2.5726 - 2.5049 1.00 1428 140 0.2658 0.3149 REMARK 3 14 2.5049 - 2.4438 0.97 1374 134 0.2904 0.3608 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.780 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2677 REMARK 3 ANGLE : 0.806 3625 REMARK 3 CHIRALITY : 0.044 391 REMARK 3 PLANARITY : 0.004 462 REMARK 3 DIHEDRAL : 18.122 1551 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 14.8030 2.5538 24.0810 REMARK 3 T TENSOR REMARK 3 T11: 0.2538 T22: 0.4598 REMARK 3 T33: 0.3353 T12: 0.0200 REMARK 3 T13: 0.0124 T23: 0.0366 REMARK 3 L TENSOR REMARK 3 L11: 0.6006 L22: 2.9566 REMARK 3 L33: 1.4454 L12: 0.2584 REMARK 3 L13: 0.3401 L23: 0.5552 REMARK 3 S TENSOR REMARK 3 S11: -0.0770 S12: -0.0139 S13: -0.0187 REMARK 3 S21: 0.0047 S22: 0.0264 S23: -0.2447 REMARK 3 S31: -0.0466 S32: 0.3103 S33: 0.0421 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VB1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-17. REMARK 100 THE DEPOSITION ID IS D_1000227153. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22390 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.444 REMARK 200 RESOLUTION RANGE LOW (A) : 48.934 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 10.80 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.44 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2P1L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M NACL, 10% GLYCEROL, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 54.70950 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 54.70950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 54.70950 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 54.70950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 54.70950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.70950 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 54.70950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.70950 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 19420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -155.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, B, A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN D 198 REMARK 465 ALA D 199 REMARK 465 ALA D 200 REMARK 465 ALA D 201 REMARK 465 GLU D 202 REMARK 465 SER D 203 REMARK 465 ARG D 204 REMARK 465 LYS D 205 REMARK 465 GLY D 206 REMARK 465 GLN D 207 REMARK 465 GLU D 208 REMARK 465 ASN B 198 REMARK 465 ALA B 199 REMARK 465 ALA B 200 REMARK 465 ALA B 201 REMARK 465 GLU B 202 REMARK 465 SER B 203 REMARK 465 ARG B 204 REMARK 465 LYS B 205 REMARK 465 GLY B 206 REMARK 465 GLN B 207 REMARK 465 GLU B 208 REMARK 465 ASP A -2 REMARK 465 GLY A -1 REMARK 465 GLY A 110 REMARK 465 GLN A 111 REMARK 465 THR A 112 REMARK 465 ASP C -2 REMARK 465 GLY C -1 REMARK 465 GLY C 110 REMARK 465 GLN C 111 REMARK 465 THR C 112 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS D 20 CG CD CE NZ REMARK 470 GLN D 26 CG CD OE1 NE2 REMARK 470 SER D 106 OG REMARK 470 HIS D 113 CG ND1 CD2 CE1 NE2 REMARK 470 GLU D 129 CG CD OE1 OE2 REMARK 470 GLU D 184 CG CD OE1 OE2 REMARK 470 LYS B 20 CG CD CE NZ REMARK 470 SER B 23 OG REMARK 470 GLN B 88 CG CD OE1 NE2 REMARK 470 ASP B 107 CG OD1 OD2 REMARK 470 GLN B 111 CG CD OE1 NE2 REMARK 470 HIS B 113 CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 121 CG CD OE1 NE2 REMARK 470 GLN B 125 CG CD OE1 NE2 REMARK 470 GLU B 129 CG CD OE1 OE2 REMARK 470 GLU A 8 CG CD OE1 OE2 REMARK 470 GLU C 8 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE D 105 -152.47 -133.65 REMARK 500 GLU D 184 1.80 -68.17 REMARK 500 PHE B 105 -159.20 -124.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VAX RELATED DB: PDB REMARK 900 RELATED ID: 5VAU RELATED DB: PDB REMARK 900 RELATED ID: 5VAY RELATED DB: PDB REMARK 900 RELATED ID: 5VB4 RELATED DB: PDB DBREF 5VB1 D 1 26 UNP Q07817 B2CL1_HUMAN 1 26 DBREF 5VB1 D 83 208 UNP Q07817 B2CL1_HUMAN 83 208 DBREF 5VB1 B 1 26 UNP Q07817 B2CL1_HUMAN 1 26 DBREF 5VB1 B 83 208 UNP Q07817 B2CL1_HUMAN 83 208 DBREF 5VB1 A -2 112 UNP Q14457 BECN1_HUMAN 105 130 DBREF 5VB1 C -2 112 UNP Q14457 BECN1_HUMAN 105 130 SEQADV 5VB1 PRO D -3 UNP Q07817 EXPRESSION TAG SEQADV 5VB1 LEU D -2 UNP Q07817 EXPRESSION TAG SEQADV 5VB1 GLY D -1 UNP Q07817 EXPRESSION TAG SEQADV 5VB1 SER D 0 UNP Q07817 EXPRESSION TAG SEQADV 5VB1 PRO B -3 UNP Q07817 EXPRESSION TAG SEQADV 5VB1 LEU B -2 UNP Q07817 EXPRESSION TAG SEQADV 5VB1 GLY B -1 UNP Q07817 EXPRESSION TAG SEQADV 5VB1 SER B 0 UNP Q07817 EXPRESSION TAG SEQRES 1 D 156 PRO LEU GLY SER MET SER GLN SER ASN ARG GLU LEU VAL SEQRES 2 D 156 VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY TYR SEQRES 3 D 156 SER TRP SER GLN MET ALA ALA VAL LYS GLN ALA LEU ARG SEQRES 4 D 156 GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG ALA SEQRES 5 D 156 PHE SER ASP LEU THR SER GLN LEU HIS ILE THR PRO GLY SEQRES 6 D 156 THR ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU LEU SEQRES 7 D 156 PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA PHE SEQRES 8 D 156 PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL ASP SEQRES 9 D 156 LYS GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA TRP SEQRES 10 D 156 MET ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP ILE SEQRES 11 D 156 GLN GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU TYR SEQRES 12 D 156 GLY ASN ASN ALA ALA ALA GLU SER ARG LYS GLY GLN GLU SEQRES 1 B 156 PRO LEU GLY SER MET SER GLN SER ASN ARG GLU LEU VAL SEQRES 2 B 156 VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY TYR SEQRES 3 B 156 SER TRP SER GLN MET ALA ALA VAL LYS GLN ALA LEU ARG SEQRES 4 B 156 GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG ALA SEQRES 5 B 156 PHE SER ASP LEU THR SER GLN LEU HIS ILE THR PRO GLY SEQRES 6 B 156 THR ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU LEU SEQRES 7 B 156 PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA PHE SEQRES 8 B 156 PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL ASP SEQRES 9 B 156 LYS GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA TRP SEQRES 10 B 156 MET ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP ILE SEQRES 11 B 156 GLN GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU TYR SEQRES 12 B 156 GLY ASN ASN ALA ALA ALA GLU SER ARG LYS GLY GLN GLU SEQRES 1 A 26 ASP GLY GLY TPO MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 A 26 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR SEQRES 1 C 26 ASP GLY GLY TPO MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 C 26 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR MODRES 5VB1 TPO A 1 THR MODIFIED RESIDUE MODRES 5VB1 TPO C 1 THR MODIFIED RESIDUE HET TPO A 1 11 HET TPO C 1 11 HETNAM TPO PHOSPHOTHREONINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 3 TPO 2(C4 H10 N O6 P) FORMUL 5 HOH *44(H2 O) HELIX 1 AA1 SER D 4 LYS D 20 1 17 HELIX 2 AA2 SER D 25 PHE D 105 1 25 HELIX 3 AA3 THR D 118 ARG D 132 1 15 HELIX 4 AA4 ASN D 136 LYS D 157 1 22 HELIX 5 AA5 VAL D 161 LEU D 178 1 18 HELIX 6 AA6 LEU D 178 GLU D 184 1 7 HELIX 7 AA7 GLY D 186 GLY D 196 1 11 HELIX 8 AA8 GLY B -1 LYS B 20 1 22 HELIX 9 AA9 SER B 25 PHE B 105 1 25 HELIX 10 AB1 THR B 115 ARG B 132 1 18 HELIX 11 AB2 ASN B 136 LYS B 157 1 22 HELIX 12 AB3 VAL B 161 LEU B 178 1 18 HELIX 13 AB4 LEU B 178 ASN B 185 1 8 HELIX 14 AB5 GLY B 186 GLY B 196 1 11 HELIX 15 AB6 TPO A 1 MET A 104 1 19 HELIX 16 AB7 TPO C 1 MET C 104 1 19 LINK C GLY A 0 N TPO A 1 1555 1555 1.33 LINK C TPO A 1 N MET A 2 1555 1555 1.33 LINK C GLY C 0 N TPO C 1 1555 1555 1.33 LINK C TPO C 1 N MET C 2 1555 1555 1.32 CRYST1 109.419 109.419 97.127 90.00 90.00 90.00 P 4 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009139 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009139 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010296 0.00000